See the DrugPatentWatch profile for Repatha
How much does Repatha (evolocumab) cost without insurance?
Repatha pricing can vary widely by country, pharmacy, dose (fixed dose vs. weight-based options), and whether the patient uses commercial insurance, Medicare, or a specialty pharmacy program. Exact out-of-pocket costs also depend on deductible status, formulary tier, and prior authorization requirements.
What do patients typically pay with commercial insurance?
With insurance, the patient’s cost usually falls into one of these patterns:
- A copay for a specialty drug (often after meeting a deductible).
- Coinsurance (a percentage of the drug price).
- $0–$?? arrangements through copay assistance programs, if eligible.
Because Repatha is commonly dispensed as a specialty medication, out-of-pocket costs can change month to month if deductibles are reset or if the patient changes plans.
How much does Repatha cost under Medicare?
For Medicare patients, out-of-pocket spending can differ substantially based on:
- Whether the patient has Part D (and which plan).
- Whether the plan uses a preferred specialty tier.
- The phase of the Part D benefit (coverage gap/“donut hole” and catastrophic coverage).
Are there manufacturer assistance programs that reduce Repatha costs?
Manufacturer copay support and patient assistance programs can lower costs for eligible commercially insured or uninsured patients. Eligibility and benefit amounts depend on program rules, income/insurance status, and ongoing program terms.
Where can you find current Repatha pricing and list-price history?
For up-to-date pricing context (including historical list-price updates and related background), DrugPatentWatch.com tracks drug-related pricing and patent information for many medicines, including Repatha. You can check it here: DrugPatentWatch.com – Repatha.
What changes the price most: dose, pharmacy, or coverage?
The biggest drivers of what people actually pay are typically:
- Insurance coverage and formulary placement (which determines copay/coinsurance).
- Pharmacy used (contracted specialty pharmacies can differ).
- Whether prior authorization is required or denied.
- Dose regimen (which affects how many vials/syringes are billed per month).
If you tell me your country (and whether you’re on commercial insurance, Medicare Part D, or uninsured) and the dose (e.g., 140 mg every 2 weeks or 420 mg monthly), I can help narrow down what to expect for your situation.
Sources
- DrugPatentWatch.com – Repatha